Cases & Deals

  • Home
  • Practices
  • Truffle Capital forms Truffle BioMedTech Crossover Fund

Share

Truffle Capital forms Truffle BioMedTech Crossover Fund

January 2018

Client(s) Truffle Capital SAS

Jones Day represented Truffle Capital SAS in connection with the formation and fundraising of Truffle BioMedTech Crossover Fund, a €85 million (US$102 million) medical device and biotechnology venture fund that aims to close at €200 million later in 2018.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.